• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻腔给药后在链霉菌中表达的结核分枝杆菌重组 Apa 蛋白在小鼠体内的免疫应答。诱导对结核杆菌气溶胶暴露的保护反应。

Immune Response to the Recombinant Apa Protein from Mycobacterium tuberculosis Expressed in Streptomyces lividans After Intranasal Administration in Mice. Induction of Protective Response to Tubercle Bacillus Aerosols Exposure.

机构信息

Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, C.P. 04510, Mexico City, Mexico.

Catedrática CONAHCYT, Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, C.P. 04510, Mexico City, Mexico.

出版信息

Curr Microbiol. 2024 May 30;81(7):197. doi: 10.1007/s00284-024-03697-7.

DOI:10.1007/s00284-024-03697-7
PMID:38816607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11139747/
Abstract

Identifying and evaluating potential vaccine candidates has become one of the main objectives to combat tuberculosis. Among them, mannosylated Apa antigen from Mycobacterium tuberculosis and the non-mannosylated protein expressed in Escherichia coli, have been studied. Although both proteins can induce a protective response in mice, it has been considered that native protein can be dispensed. In this work, we study the protective response induced by Apa expressed in E. coli and in Streptomyces lividans. The latter, like native is secreted as a double band of 45/47 kDa, however, only its 47 kDa band is mannosylated. Both antigens and BCG were intranasal administrated in mice, and animals were then challenged by aerosol with M. tuberculosis H37Rv. The results showed that both, Apa from S. lividans and E. coli conferred statistically significantly protection to animals compared to controls. The cytokine immune response was studied by an immunoassay after animals' immunization, revealing that Apa from S. lividans induced a statistically significant proliferation of T cell, as well as the expression of IFN-γ, IL-1β, IL-17 and IL-10. In contrast, non-proliferation was obtained with non-mannosylated protein, but induction of IL-12 and IL-17 was observed. Together, these results demonstrate that both proteins were able to modulate a specific immune response against M. tuberculosis, that could be driven by different mechanisms possibly associated with the presence or not of mannosylation. Furthermore, stimulation of cells from BCG-vaccinated animals with the proteins could be an important tool, to help define the use of a given subunit-vaccine after BCG vaccination.

摘要

鉴定和评估潜在的疫苗候选物已成为对抗结核病的主要目标之一。其中,已研究了结核分枝杆菌的甘露糖化 Apa 抗原和大肠杆菌中表达的非甘露糖化蛋白。尽管这两种蛋白质都可以在小鼠中诱导保护性反应,但人们认为可以不用天然蛋白。在这项工作中,我们研究了在大肠杆菌和链霉菌中表达的 Apa 诱导的保护性反应。后者与天然蛋白一样,作为 45/47 kDa 的双带分泌,但只有其 47 kDa 带是甘露糖化的。两种抗原和卡介苗都通过鼻腔给药给小鼠,然后用结核分枝杆菌 H37Rv 气溶胶对动物进行攻击。结果表明,与对照组相比,来自 S. lividans 和 E. coli 的 Apa 都能使动物获得统计学上显著的保护。通过免疫测定研究了动物免疫后的细胞因子免疫反应,结果表明,来自 S. lividans 的 Apa 诱导了 T 细胞的统计学上显著增殖,以及 IFN-γ、IL-1β、IL-17 和 IL-10 的表达。相比之下,未甘露糖化的蛋白未引起增殖,但观察到了 IL-12 和 IL-17 的诱导。总之,这些结果表明,这两种蛋白都能够调节针对结核分枝杆菌的特异性免疫反应,这可能是由不同的机制驱动的,可能与甘露糖化的存在与否有关。此外,用这些蛋白刺激卡介苗接种动物的细胞可能是一个重要的工具,可以帮助确定在卡介苗接种后使用特定的亚单位疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/07231b757aa6/284_2024_3697_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/c68c53081623/284_2024_3697_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/926aec31e5c2/284_2024_3697_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/03078137adf7/284_2024_3697_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/31d3a1d7ee29/284_2024_3697_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/07231b757aa6/284_2024_3697_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/c68c53081623/284_2024_3697_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/926aec31e5c2/284_2024_3697_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/03078137adf7/284_2024_3697_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/31d3a1d7ee29/284_2024_3697_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef80/11139747/07231b757aa6/284_2024_3697_Fig5_HTML.jpg

相似文献

1
Immune Response to the Recombinant Apa Protein from Mycobacterium tuberculosis Expressed in Streptomyces lividans After Intranasal Administration in Mice. Induction of Protective Response to Tubercle Bacillus Aerosols Exposure.经鼻腔给药后在链霉菌中表达的结核分枝杆菌重组 Apa 蛋白在小鼠体内的免疫应答。诱导对结核杆菌气溶胶暴露的保护反应。
Curr Microbiol. 2024 May 30;81(7):197. doi: 10.1007/s00284-024-03697-7.
2
Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.一种结合五种Esx家族蛋白的融合蛋白结核疫苗的免疫原性和保护效力
Front Cell Infect Microbiol. 2017 May 31;7:226. doi: 10.3389/fcimb.2017.00226. eCollection 2017.
3
Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv.结核分枝杆菌 H37Rv 高特异性抗原嵌合体的免疫特性分析。
Tuberculosis (Edinb). 2021 Mar;127:102054. doi: 10.1016/j.tube.2021.102054. Epub 2021 Jan 28.
4
Proof of concept in utilizing in-trans surface display system of Lactobacillus plantarum as mucosal tuberculosis vaccine via oral administration in mice.利用植物乳杆菌在体表面展示系统通过口服途径在小鼠中作为黏膜结核疫苗的概念验证。
BMC Biotechnol. 2018 Oct 11;18(1):63. doi: 10.1186/s12896-018-0461-y.
5
Comparison of different immunization routes on the immune responses induced by Mycobacterium tuberculosis ESAT-6/CFP-10 recombinant protein.结核分枝杆菌ESAT-6/CFP-10重组蛋白诱导的免疫反应中不同免疫途径的比较
Biologicals. 2019 May;59:6-11. doi: 10.1016/j.biologicals.2019.04.002. Epub 2019 Apr 20.
6
[Preparation of TAT-Ag85B protein vaccine and evaluation of its anti-Myobacterium tuberculosis effect].[TAT-Ag85B蛋白疫苗的制备及其抗结核分枝杆菌效果评价]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Jan;31(1):49-53.
7
In vivo electroporation of a codon-optimized BER DNA vaccine protects mice from pathogenic Mycobacterium tuberculosis aerosol challenge.对密码子优化的碱基切除修复(BER)DNA疫苗进行体内电穿孔可保护小鼠免受致病性结核分枝杆菌气溶胶攻击。
Tuberculosis (Edinb). 2018 Dec;113:65-75. doi: 10.1016/j.tube.2018.07.003. Epub 2018 Jul 10.
8
Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.新型重组牛型分枝杆菌卡介苗菌株表达人细胞因子白细胞介素-12p70 和结核分枝杆菌 Ag85A 融合蛋白的免疫原性和保护效力。
Scand J Immunol. 2013 Dec;78(6):497-506. doi: 10.1111/sji.12116.
9
Immunogenic profiling of Mycobacterium tuberculosis Rv1513 reveals its ability to switch on Th1 based immunity.结核分枝杆菌 Rv1513 的免疫原性分析揭示了其诱导 Th1 型免疫的能力。
Arch Microbiol. 2024 Jul 16;206(8):352. doi: 10.1007/s00203-024-04033-0.
10
-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice.- 载体多抗原结核疫苗增强了卡介苗免疫的 C57BL/6 和 BALB/c 小鼠对有毒力结核分枝杆菌气溶胶挑战的保护性免疫。
mBio. 2022 Jun 28;13(3):e0068722. doi: 10.1128/mbio.00687-22. Epub 2022 Jun 1.

本文引用的文献

1
Vaccines against Tuberculosis: Where Are We Now?抗结核疫苗:我们目前的进展如何?
Vaccines (Basel). 2023 May 22;11(5):1013. doi: 10.3390/vaccines11051013.
2
A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin.一种结核分枝杆菌特异性亚单位疫苗,与卡介苗联合使用可提供协同免疫。
Nat Commun. 2021 Nov 18;12(1):6658. doi: 10.1038/s41467-021-26934-0.
3
New Insights into the Methylation of Heparin Binding Hemagglutinin Adhesin Expressed in .关于在……中表达的肝素结合血凝素黏附素甲基化的新见解。
Pathogens. 2021 Sep 4;10(9):1139. doi: 10.3390/pathogens10091139.
4
Comparison of three infectious routes in mice.三种感染途径在小鼠中的比较。
Virulence. 2021 Dec;12(1):2562-2570. doi: 10.1080/21505594.2021.1980179.
5
The 100 anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19.卡介苗(BCG)问世100周年与最新的新冠疫苗
Int J Tuberc Lung Dis. 2021 Aug 1;25(8):611-613. doi: 10.5588/ijtld.21.0372.
6
An Overview of the Development of New Vaccines for Tuberculosis.结核病新型疫苗研发概述
Vaccines (Basel). 2020 Oct 5;8(4):586. doi: 10.3390/vaccines8040586.
7
Animal Models of Mycobacteria Infection.分枝杆菌感染的动物模型
Curr Protoc Immunol. 2020 Jun;129(1):e98. doi: 10.1002/cpim.98.
8
Tuberculosis vaccine: A journey from BCG to present.结核疫苗:从卡介苗到现在的历程。
Life Sci. 2020 Jul 1;252:117594. doi: 10.1016/j.lfs.2020.117594. Epub 2020 Apr 16.
9
Route of Infection Strongly Impacts the Host-Pathogen Relationship.感染途径强烈影响宿主-病原体关系。
Front Immunol. 2019 Jul 11;10:1589. doi: 10.3389/fimmu.2019.01589. eCollection 2019.
10
Next-Generation Vaccines Based on Bacille Calmette-Guérin.基于卡介苗的新一代疫苗。
Front Immunol. 2018 Feb 5;9:121. doi: 10.3389/fimmu.2018.00121. eCollection 2018.